Vir Biotechnology, Inc.
VIR
20 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 4:35 PM | Vicki L SatoDirector | Sale | 22,000 | $10.05 | $221.0K | 1,078,391(D) | View → |
| Apr 30, 2026 | Apr 30 1:55 PM | Eisner Mark | Proposed Sale | 88,958 | $10.30 | $916.3K | — | View → |
| Apr 6, 2026 | Apr 7 8:50 PM | Backer Marianne DeDirector, President and CEO | Sale | 72,559 | $9.16 | $664.4K | 948,145(D) | View → |
| Apr 6, 2026 | Apr 6 7:23 PM | De Backer Marianne | Proposed Sale | 72,559 | $9.16 | $664.3K | — | View → |
| Apr 1, 2026 | Apr 2 2:46 PM | Vicki L SatoDirector | Sale | 22,000 | $9.07 | $199.6K | 1,100,391(D) | View → |
| Mar 23, 2026 | Mar 24 8:35 PM | Brent SabatiniSVP, Chief Accounting Officer | Sale | 7,711 | $9.12 | $70.3K | 61,902(D) | View → |
| Mar 23, 2026 | Mar 23 1:42 PM | Sabatini Brent | Proposed Sale | 7,711 | $9.12 | $70.3K | — | View → |
| Mar 2, 2026 | Mar 3 5:10 PM | Vicki L SatoDirector | Sale | 22,000 | $9.51 | $209.2K | 1,122,391(D) | View → |
| Mar 2, 2026 | Mar 2 9:35 PM | VICKI LEE SATO | Proposed Sale | 88,000 | $9.09 | $799.9K | — | View → |
| Feb 24, 2026 | Feb 26 9:56 PM | Vicki L SatoDirector | Sale | 42,377 | $9.75 | $413.4K | 1,144,391(D) | View → |
| Feb 24, 2026 | Feb 26 9:56 PM | Brent SabatiniSVP, Chief Accounting Officer | Sale | 1,430 | $9.53 | $13.6K | 69,613(D) | View → |
| Feb 24, 2026 | Feb 26 9:55 PM | Jason O'ByrneEVP & Chief Financial Officer | Sale | 1,634 | $9.53 | $15.6K | 162,615(D) | View → |
| Feb 25, 2026 | Feb 26 9:55 PM | Mark EisnerEVP and Chief Medical Officer | Sale | 1,889 | $9.82 | $18.5K | 154,024(D) | View → |
| Feb 24, 2026 | Feb 26 9:55 PM | Mark EisnerEVP and Chief Medical Officer | Sale | 1,616 | $9.53 | $15.4K | 155,913(D) | View → |
| Feb 25, 2026 | Feb 26 9:54 PM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Sale | 13,700 | $9.82 | $134.5K | 112,982(D) | View → |
| Feb 24, 2026 | Feb 26 9:54 PM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Sale | 3,117 | $9.53 | $29.7K | 126,682(D) | View → |
| Feb 24, 2026 | Feb 26 9:54 PM | Backer Marianne DeDirector, Chief Executive Officer | Sale | 14,762 | $9.53 | $140.7K | 1,020,704(D) | View → |
| Feb 25, 2026 | Feb 26 2:00 AM | SVF Endurance (Cayman) Limited | Proposed Sale | 400,000 | $9.49 | $3.8M | — | View → |
| Feb 25, 2026 | Feb 25 3:48 PM | de Verneuil Vanina | Proposed Sale | 13,700 | $9.82 | $134.5K | — | View → |
| Feb 25, 2026 | Feb 25 2:48 PM | Eisner Mark | Proposed Sale | 1,889 | $9.82 | $18.5K | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Feb 26 9:56 PM | Vicki L SatoDirector | Option Exercise | 42,377 | $1.49 | 0(D) | View → |
| Feb 22, 2026 | Feb 25 12:13 AM | Brent SabatiniSVP, Chief Accounting Officer | Grant/Award | 50,000 | $7.56 | 50,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:12 AM | Jason O'ByrneEVP & Chief Financial Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:11 AM | Mark EisnerEVP and Chief Medical Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:10 AM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:09 AM | Backer Marianne DeDirector, Chief Executive Officer | Grant/Award | 570,000 | $7.56 | 570,000(D) | View → |